| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of interleukin-2 production | 5.88e-07 | 42 | 80 | 5 | GO:0032743 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 6.61e-06 | 10 | 80 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 6.61e-06 | 10 | 80 | 3 | GO:0046543 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 9.07e-06 | 11 | 80 | 3 | GO:0070669 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-2 production | 1.01e-05 | 74 | 80 | 5 | GO:0032663 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 1.21e-05 | 12 | 80 | 3 | GO:0070672 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 1.56e-05 | 13 | 80 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | interleukin-2 production | 1.67e-05 | 82 | 80 | 5 | GO:0032623 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 4.45e-05 | 3 | 80 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 4.45e-05 | 3 | 80 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 4.45e-05 | 3 | 80 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 4.45e-05 | 3 | 80 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 8.16e-05 | 114 | 80 | 5 | GO:0033077 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 8.87e-05 | 4 | 80 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.17e-04 | 382 | 80 | 8 | GO:0030217 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 1.37e-04 | 26 | 80 | 3 | GO:0060396 | |
| GeneOntologyBiologicalProcess | cytokinesis | 1.42e-04 | 204 | 80 | 6 | GO:0000910 | |
| GeneOntologyBiologicalProcess | T cell selection | 1.50e-04 | 69 | 80 | 4 | GO:0045058 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 1.54e-04 | 27 | 80 | 3 | GO:0071378 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TTC8 MYH2 MYH8 HMCN1 SPTBN1 MINK1 GJC1 IL1A TRIP10 IQGAP3 MAP3K1 IQGAP1 | 1.96e-04 | 912 | 80 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 2.31e-04 | 537 | 80 | 9 | GO:0030098 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 2.82e-04 | 33 | 80 | 3 | GO:0046629 | |
| GeneOntologyBiologicalProcess | mitotic cytokinetic process | 2.82e-04 | 33 | 80 | 3 | GO:1902410 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 2.82e-04 | 33 | 80 | 3 | GO:0060740 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-9 | 3.08e-04 | 7 | 80 | 2 | GO:0071355 | |
| GeneOntologyBiologicalProcess | interleukin-9-mediated signaling pathway | 3.08e-04 | 7 | 80 | 2 | GO:0038113 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 3.08e-04 | 34 | 80 | 3 | GO:0060512 | |
| GeneOntologyBiologicalProcess | cell division | HMCN1 STAG1 TTC28 PKP4 SPTBN1 IL1A UVRAG IQGAP3 IQGAP1 CEP55 | 3.55e-04 | 697 | 80 | 10 | GO:0051301 |
| GeneOntologyBiologicalProcess | cell cycle process | FEM1B STAG1 WNT5A PKP4 SPTBN1 SMARCC2 MSH4 PLCG2 CCDC102B PIBF1 IL1A UVRAG IQGAP3 IQGAP1 CEP55 | 3.80e-04 | 1441 | 80 | 15 | GO:0022402 |
| GeneOntologyBiologicalProcess | response to interleukin-9 | 4.10e-04 | 8 | 80 | 2 | GO:0071104 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 4.37e-04 | 586 | 80 | 9 | GO:0001819 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 5.11e-04 | 95 | 80 | 4 | GO:0000281 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 5.25e-04 | 9 | 80 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 5.25e-04 | 9 | 80 | 2 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 5.25e-04 | 9 | 80 | 2 | GO:0000912 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-2 | 5.25e-04 | 9 | 80 | 2 | GO:0071352 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 5.25e-04 | 9 | 80 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | interleukin-2-mediated signaling pathway | 5.25e-04 | 9 | 80 | 2 | GO:0038110 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 5.39e-04 | 41 | 80 | 3 | GO:0060416 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 6.55e-04 | 10 | 80 | 2 | GO:0044837 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-15 | 7.99e-04 | 11 | 80 | 2 | GO:0071350 | |
| GeneOntologyBiologicalProcess | interleukin-15-mediated signaling pathway | 7.99e-04 | 11 | 80 | 2 | GO:0035723 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 7.99e-04 | 11 | 80 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | positive regulation of JNK cascade | 8.00e-04 | 107 | 80 | 4 | GO:0046330 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 8.21e-04 | 640 | 80 | 9 | GO:1903131 | |
| GeneOntologyBiologicalProcess | cytokinetic process | 8.57e-04 | 48 | 80 | 3 | GO:0032506 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 8.57e-04 | 48 | 80 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HMCN1 WNT5A PKP4 MINK1 LAMA3 SMARCC2 LOXL3 IL1A CCDC88B PDIA3 STAT5A STAT5B | 8.71e-04 | 1077 | 80 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | WNT5A PKP4 MINK1 LAMA3 SMARCC2 LOXL3 IL1A CCDC88B STAT5A STAT5B IQGAP1 | 8.74e-04 | 927 | 80 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 9.56e-04 | 12 | 80 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 9.56e-04 | 12 | 80 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | GMNC FEM1B TTC28 WNT5A PKP4 SMARCC2 PLCG2 IL1A UVRAG STAT3 STAT5A STAT5B IQGAP1 | 1.03e-03 | 1256 | 80 | 13 | GO:0051726 |
| Domain | STAT_TF_prot_interaction | 2.15e-06 | 7 | 75 | 3 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 2.15e-06 | 7 | 75 | 3 | IPR012345 | |
| Domain | STAT | 2.15e-06 | 7 | 75 | 3 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 2.15e-06 | 7 | 75 | 3 | IPR015988 | |
| Domain | - | 2.15e-06 | 7 | 75 | 3 | 2.60.40.630 | |
| Domain | STAT_int | 2.15e-06 | 7 | 75 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.15e-06 | 7 | 75 | 3 | IPR013801 | |
| Domain | STAT_bind | 2.15e-06 | 7 | 75 | 3 | PF02864 | |
| Domain | STAT_int | 2.15e-06 | 7 | 75 | 3 | PF02865 | |
| Domain | - | 2.15e-06 | 7 | 75 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.15e-06 | 7 | 75 | 3 | PF01017 | |
| Domain | - | 2.15e-06 | 7 | 75 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_alpha | 3.43e-06 | 8 | 75 | 3 | IPR013800 | |
| Domain | DGCR6 | 1.59e-05 | 2 | 75 | 2 | PF07324 | |
| Domain | Gonadal | 1.59e-05 | 2 | 75 | 2 | IPR010849 | |
| Domain | RasGAP_C | 4.76e-05 | 3 | 75 | 2 | IPR000593 | |
| Domain | RasGAP_C | 4.76e-05 | 3 | 75 | 2 | PF03836 | |
| Domain | Myosin-like_IQ_dom | 5.75e-05 | 19 | 75 | 3 | IPR027401 | |
| Domain | - | 5.75e-05 | 19 | 75 | 3 | 4.10.270.10 | |
| Domain | IQ | 1.90e-04 | 71 | 75 | 4 | PF00612 | |
| Domain | IQ | 3.16e-04 | 81 | 75 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.72e-04 | 90 | 75 | 4 | IPR000048 | |
| Domain | IQ | 5.34e-04 | 93 | 75 | 4 | PS50096 | |
| Domain | TPR_7 | 7.01e-04 | 10 | 75 | 2 | PF13176 | |
| Domain | SH2 | 7.29e-04 | 101 | 75 | 4 | PF00017 | |
| Domain | SH2 | 1.00e-03 | 110 | 75 | 4 | SM00252 | |
| Domain | SH2 | 1.04e-03 | 111 | 75 | 4 | PS50001 | |
| Domain | TPR_2 | 1.06e-03 | 50 | 75 | 3 | PF07719 | |
| Domain | TPR_2 | 1.06e-03 | 50 | 75 | 3 | IPR013105 | |
| Domain | SH2 | 1.07e-03 | 112 | 75 | 4 | IPR000980 | |
| Domain | - | 1.07e-03 | 112 | 75 | 4 | 3.30.505.10 | |
| Domain | p53-like_TF_DNA-bd | 1.26e-03 | 53 | 75 | 3 | IPR008967 | |
| Domain | RasGAP | 1.40e-03 | 14 | 75 | 2 | SM00323 | |
| Domain | RasGAP_CS | 1.40e-03 | 14 | 75 | 2 | IPR023152 | |
| Domain | RasGAP | 1.62e-03 | 15 | 75 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 1.62e-03 | 15 | 75 | 2 | PS00509 | |
| Domain | Myosin_N | 1.62e-03 | 15 | 75 | 2 | PF02736 | |
| Domain | RAS_GTPASE_ACTIV_2 | 1.62e-03 | 15 | 75 | 2 | PS50018 | |
| Domain | Myosin_N | 1.62e-03 | 15 | 75 | 2 | IPR004009 | |
| Domain | - | 1.84e-03 | 16 | 75 | 2 | 1.10.506.10 | |
| Domain | CH | 2.27e-03 | 65 | 75 | 3 | SM00033 | |
| Domain | Myosin_tail_1 | 2.34e-03 | 18 | 75 | 2 | PF01576 | |
| Domain | Myosin_tail | 2.34e-03 | 18 | 75 | 2 | IPR002928 | |
| Domain | RasGAP_dom | 2.34e-03 | 18 | 75 | 2 | IPR001936 | |
| Domain | CH | 2.81e-03 | 70 | 75 | 3 | PF00307 | |
| Domain | - | 2.92e-03 | 71 | 75 | 3 | 1.10.418.10 | |
| Domain | CH | 3.16e-03 | 73 | 75 | 3 | PS50021 | |
| Domain | CH-domain | 3.41e-03 | 75 | 75 | 3 | IPR001715 | |
| Domain | TPR_REGION | 4.39e-03 | 165 | 75 | 4 | PS50293 | |
| Domain | TPR | 4.39e-03 | 165 | 75 | 4 | PS50005 | |
| Domain | - | 4.50e-03 | 25 | 75 | 2 | 3.10.250.10 | |
| Domain | HR1_rho-bd | 4.50e-03 | 25 | 75 | 2 | IPR011072 | |
| Domain | SRCR_1 | 4.86e-03 | 26 | 75 | 2 | PS00420 | |
| Domain | SRCR_2 | 4.86e-03 | 26 | 75 | 2 | PS50287 | |
| Domain | SRCR-like_dom | 4.86e-03 | 26 | 75 | 2 | IPR017448 | |
| Domain | SRCR | 5.23e-03 | 27 | 75 | 2 | IPR001190 | |
| Domain | TPR_1 | 5.69e-03 | 90 | 75 | 3 | PF00515 | |
| Domain | TPR_1 | 5.69e-03 | 90 | 75 | 3 | IPR001440 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 6.57e-07 | 5 | 58 | 3 | M48987 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.31e-06 | 6 | 58 | 3 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.31e-06 | 6 | 58 | 3 | MM15621 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 2.29e-06 | 7 | 58 | 3 | M47430 | |
| Pathway | PID_RAC1_PATHWAY | 2.68e-06 | 54 | 58 | 5 | M278 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 5.46e-06 | 9 | 58 | 3 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 5.46e-06 | 9 | 58 | 3 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 5.46e-06 | 9 | 58 | 3 | M8066 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 5.67e-06 | 29 | 58 | 4 | M39616 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 7.77e-06 | 10 | 58 | 3 | M27898 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.07e-05 | 11 | 58 | 3 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.07e-05 | 11 | 58 | 3 | MM15578 | |
| Pathway | BIOCARTA_IL10_PATHWAY | 1.42e-05 | 12 | 58 | 3 | MM1416 | |
| Pathway | BIOCARTA_IL10_PATHWAY | 1.84e-05 | 13 | 58 | 3 | M6778 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.33e-05 | 14 | 58 | 3 | M27858 | |
| Pathway | WP_FOXP3_IN_COVID19 | 2.90e-05 | 15 | 58 | 3 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.90e-05 | 15 | 58 | 3 | MM14536 | |
| Pathway | WP_IL9_SIGNALING | 4.31e-05 | 17 | 58 | 3 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 4.31e-05 | 17 | 58 | 3 | M47905 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 5.16e-05 | 18 | 58 | 3 | M673 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 6.11e-05 | 19 | 58 | 3 | M41732 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 7.17e-05 | 20 | 58 | 3 | MM15496 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 7.17e-05 | 20 | 58 | 3 | M39002 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.10e-04 | 23 | 58 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.10e-04 | 23 | 58 | 3 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 1.10e-04 | 23 | 58 | 3 | M47904 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.26e-04 | 24 | 58 | 3 | M11520 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.26e-04 | 24 | 58 | 3 | M519 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 1.43e-04 | 25 | 58 | 3 | M41829 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.43e-04 | 25 | 58 | 3 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.43e-04 | 25 | 58 | 3 | M27865 | |
| Pathway | WP_IL7_SIGNALING | 1.43e-04 | 25 | 58 | 3 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.61e-04 | 26 | 58 | 3 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.61e-04 | 26 | 58 | 3 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.61e-04 | 26 | 58 | 3 | MM15896 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 1.65e-04 | 5 | 58 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 1.65e-04 | 5 | 58 | 2 | M49006 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.80e-04 | 27 | 58 | 3 | MM14712 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 1.80e-04 | 27 | 58 | 3 | M1909 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.01e-04 | 28 | 58 | 3 | MM1386 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 2.01e-04 | 28 | 58 | 3 | M41724 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.01e-04 | 28 | 58 | 3 | M2529 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 2.15e-04 | 72 | 58 | 4 | M39738 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.24e-04 | 29 | 58 | 3 | MM1452 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.24e-04 | 29 | 58 | 3 | M779 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.36e-04 | 136 | 58 | 5 | M42547 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 2.48e-04 | 30 | 58 | 3 | M41825 | |
| Pathway | WP_JOUBERT_SYNDROME | 2.65e-04 | 76 | 58 | 4 | M39835 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 2.74e-04 | 31 | 58 | 3 | M661 | |
| Pathway | PID_EPO_PATHWAY | 3.30e-04 | 33 | 58 | 3 | M233 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 3.45e-04 | 7 | 58 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 3.45e-04 | 7 | 58 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 3.45e-04 | 7 | 58 | 2 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 3.45e-04 | 7 | 58 | 2 | M27907 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 3.61e-04 | 34 | 58 | 3 | M48081 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.94e-04 | 35 | 58 | 3 | MM15144 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 4.29e-04 | 36 | 58 | 3 | M542 | |
| Pathway | PID_GMCSF_PATHWAY | 4.29e-04 | 36 | 58 | 3 | M22 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 4.65e-04 | 37 | 58 | 3 | MM14564 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 5.03e-04 | 38 | 58 | 3 | M27536 | |
| Pathway | WP_EGFEGFR_SIGNALING | 5.28e-04 | 162 | 58 | 5 | M39334 | |
| Pathway | WP_IL5_SIGNALING | 5.86e-04 | 40 | 58 | 3 | M39392 | |
| Pathway | WP_IL2_SIGNALING | 6.77e-04 | 42 | 58 | 3 | M39536 | |
| Pathway | PID_TCPTP_PATHWAY | 6.77e-04 | 42 | 58 | 3 | M91 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 7.26e-04 | 43 | 58 | 3 | MM15864 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 7.26e-04 | 43 | 58 | 3 | M508 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 7.33e-04 | 10 | 58 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 7.33e-04 | 10 | 58 | 2 | MM15618 | |
| Pathway | PID_CXCR4_PATHWAY | 7.54e-04 | 100 | 58 | 4 | M124 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 7.77e-04 | 44 | 58 | 3 | M1012 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 8.30e-04 | 45 | 58 | 3 | M47408 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 9.42e-04 | 47 | 58 | 3 | M39380 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.03e-03 | 188 | 58 | 5 | MM15828 | |
| Pathway | WP_IL3_SIGNALING | 1.06e-03 | 49 | 58 | 3 | M39722 | |
| Pathway | WP_IL10_ANTIINFLAMMATORY_SIGNALING | 1.07e-03 | 12 | 58 | 2 | M39796 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.07e-03 | 12 | 58 | 2 | M27893 | |
| Pathway | REACTOME_LYSINE_CATABOLISM | 1.07e-03 | 12 | 58 | 2 | M27680 | |
| Pathway | REACTOME_LYSINE_CATABOLISM | 1.07e-03 | 12 | 58 | 2 | MM15400 | |
| Pathway | PID_PTP1B_PATHWAY | 1.27e-03 | 52 | 58 | 3 | M50 | |
| Pathway | WP_IL4_SIGNALING | 1.41e-03 | 54 | 58 | 3 | M39720 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 1.41e-03 | 54 | 58 | 3 | M39435 | |
| Pathway | PID_IL5_PATHWAY | 1.47e-03 | 14 | 58 | 2 | M135 | |
| Pathway | PID_IL2_1PATHWAY | 1.49e-03 | 55 | 58 | 3 | M122 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 1.65e-03 | 57 | 58 | 3 | M19888 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.65e-03 | 57 | 58 | 3 | MM14713 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.69e-03 | 15 | 58 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.69e-03 | 15 | 58 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M17681 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.74e-03 | 58 | 58 | 3 | M2049 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.74e-03 | 58 | 58 | 3 | MM15602 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.82e-03 | 59 | 58 | 3 | M39350 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.82e-03 | 59 | 58 | 3 | M41812 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.92e-03 | 16 | 58 | 2 | MM15710 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.92e-03 | 16 | 58 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.92e-03 | 16 | 58 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.92e-03 | 16 | 58 | 2 | M41733 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.94e-03 | 129 | 58 | 4 | M186 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 2.03e-03 | 219 | 58 | 5 | M29836 | |
| Pathway | PID_IL12_2PATHWAY | 2.10e-03 | 62 | 58 | 3 | M54 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.12e-03 | 325 | 58 | 6 | M12868 | |
| Pubmed | Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. | 1.17e-08 | 3 | 80 | 3 | 20201032 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 19796718 | ||
| Pubmed | IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts. | 1.17e-08 | 3 | 80 | 3 | 9398404 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 18342552 | ||
| Pubmed | IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. | 4.68e-08 | 4 | 80 | 3 | 32332067 | |
| Pubmed | Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. | 4.68e-08 | 4 | 80 | 3 | 25205818 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 7719938 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 25352693 | ||
| Pubmed | Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. | 4.68e-08 | 4 | 80 | 3 | 15634877 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 23696567 | ||
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 17639043 | ||
| Pubmed | STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. | 4.68e-08 | 4 | 80 | 3 | 23716595 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 28422733 | ||
| Pubmed | IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. | 6.04e-08 | 17 | 80 | 4 | 19666510 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ZNF106 SETX TTC28 AASS SPTBN1 MINK1 FRYL PIBF1 ZNF598 DNMBP UVRAG STAT3 LUZP1 | 8.19e-08 | 861 | 80 | 13 | 36931259 |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 29794014 | ||
| Pubmed | The Current STATus of lymphocyte signaling: new roles for old players. | 1.17e-07 | 5 | 80 | 3 | 19362457 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 23033267 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 15677474 | ||
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 2.33e-07 | 6 | 80 | 3 | 14704793 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 17082570 | ||
| Pubmed | Nonredundant roles for Stat5a/b in directly regulating Foxp3. | 2.33e-07 | 6 | 80 | 3 | 17227828 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 21278738 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 27870635 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 12704203 | ||
| Pubmed | Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. | 2.33e-07 | 6 | 80 | 3 | 17363300 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 10675904 | ||
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 17951529 | ||
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 4.07e-07 | 7 | 80 | 3 | 30718218 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 4.07e-07 | 7 | 80 | 3 | 12039028 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 4.07e-07 | 7 | 80 | 3 | 12634107 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 4.07e-07 | 7 | 80 | 3 | 24058793 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 4.07e-07 | 7 | 80 | 3 | 10526573 | |
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 6.51e-07 | 8 | 80 | 3 | 9989503 | |
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 10602027 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 10781830 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 15644415 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 9484840 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 20065083 | ||
| Pubmed | Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. | 1.39e-06 | 10 | 80 | 3 | 11161808 | |
| Pubmed | 1.39e-06 | 10 | 80 | 3 | 10200816 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 1.39e-06 | 10 | 80 | 3 | 38658806 | |
| Pubmed | A brain-specific homeobox gene, Bsx, is essential for proper postnatal growth and nursing. | 1.39e-06 | 10 | 80 | 3 | 17485440 | |
| Pubmed | 1.39e-06 | 10 | 80 | 3 | 24069548 | ||
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 3.30e-06 | 13 | 80 | 3 | 8530075 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.01e-06 | 281 | 80 | 7 | 28706196 | |
| Pubmed | 4.19e-06 | 14 | 80 | 3 | 12753872 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23151802 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26999798 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20167868 | ||
| Pubmed | The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia. | 5.23e-06 | 2 | 80 | 2 | 26146825 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 5.23e-06 | 2 | 80 | 2 | 31443474 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12377952 | ||
| Pubmed | Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. | 5.23e-06 | 2 | 80 | 2 | 19995546 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15998795 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 5.23e-06 | 2 | 80 | 2 | 21127177 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16289657 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 25552366 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 25470773 | ||
| Pubmed | STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells. | 5.23e-06 | 2 | 80 | 2 | 26976954 | |
| Pubmed | ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum. | 5.23e-06 | 2 | 80 | 2 | 20022947 | |
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 5.23e-06 | 2 | 80 | 2 | 21431790 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30612517 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 28500076 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21826656 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 5.23e-06 | 2 | 80 | 2 | 27264955 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 22159083 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20008792 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 33199496 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23243289 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16502315 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12217382 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31599926 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 10594041 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21036145 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 33948920 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 10486277 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 19491198 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 5.23e-06 | 2 | 80 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 5.23e-06 | 2 | 80 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 5.23e-06 | 2 | 80 | 2 | 30377054 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 5.23e-06 | 2 | 80 | 2 | 32790723 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 18492722 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 10066807 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 10835485 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 35464049 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 5.23e-06 | 2 | 80 | 2 | 23773921 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 5.23e-06 | 2 | 80 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 5.23e-06 | 2 | 80 | 2 | 24878107 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 28065600 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12847485 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12835478 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 5.23e-06 | 2 | 80 | 2 | 24497979 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17536022 | ||
| Interaction | NIN interactions | 1.01e-05 | 359 | 78 | 9 | int:NIN | |
| Interaction | NINL interactions | TTC28 PKP4 CC2D2A PIBF1 ZNF598 DNMBP IQGAP3 LUZP1 IQGAP1 CEP55 | 1.05e-05 | 458 | 78 | 10 | int:NINL |
| Interaction | WEE2-AS1 interactions | 4.05e-05 | 163 | 78 | 6 | int:WEE2-AS1 | |
| Interaction | ZC2HC1C interactions | 4.31e-05 | 100 | 78 | 5 | int:ZC2HC1C | |
| Interaction | DSCAM interactions | 5.30e-05 | 171 | 78 | 6 | int:DSCAM | |
| Interaction | CEP120 interactions | 5.70e-05 | 106 | 78 | 5 | int:CEP120 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.83e-04 | 473 | 80 | 6 | chr17q21 | |
| GeneFamily | SH2 domain containing | 1.60e-04 | 101 | 49 | 4 | 741 | |
| GeneFamily | Myosin heavy chains | 7.39e-04 | 15 | 49 | 2 | 1098 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-07 | 158 | 80 | 6 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-07 | 158 | 80 | 6 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-07 | 158 | 80 | 6 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 184 | 80 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-06 | 200 | 80 | 6 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.45e-06 | 157 | 80 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 171 | 80 | 5 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.55e-05 | 174 | 80 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 176 | 80 | 5 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 176 | 80 | 5 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.14e-05 | 186 | 80 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.20e-05 | 187 | 80 | 5 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-05 | 190 | 80 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-05 | 195 | 80 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-05 | 195 | 80 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 195 | 80 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 195 | 80 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 199 | 80 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 101 | 80 | 4 | c075aa59acf333b05b6533b8172dc0c5c31b6ed3 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 101 | 80 | 4 | be1c3034c2ebe64b7dd7a9b31ea43336ea1eeb73 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 101 | 80 | 4 | 8ce6ebda05081dbd7db891e5da8af9cc7d4beacb | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 101 | 80 | 4 | a5a3a79f7a61dd4528615c3abaced1c176fd137a | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.42e-05 | 132 | 80 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 146 | 80 | 4 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 154 | 80 | 4 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 158 | 80 | 4 | 78a8a498a9c84ed65e0eefaac781d5247c5b477a | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.93e-04 | 159 | 80 | 4 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.93e-04 | 159 | 80 | 4 | 1dde4d19cc0fde7ebbccb4c31bb845a92206021b | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 160 | 80 | 4 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 160 | 80 | 4 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 168 | 80 | 4 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 2.43e-04 | 169 | 80 | 4 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.49e-04 | 170 | 80 | 4 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-04 | 171 | 80 | 4 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 171 | 80 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 171 | 80 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-04 | 173 | 80 | 4 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 2.66e-04 | 173 | 80 | 4 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-04 | 174 | 80 | 4 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-04 | 174 | 80 | 4 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-04 | 175 | 80 | 4 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 176 | 80 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 176 | 80 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 2.84e-04 | 176 | 80 | 4 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 178 | 80 | 4 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 3.16e-04 | 181 | 80 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 3.16e-04 | 181 | 80 | 4 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-04 | 181 | 80 | 4 | 0bc58c8942491e7ee5b858c5742770df7677532f | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 3.16e-04 | 181 | 80 | 4 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 3.16e-04 | 181 | 80 | 4 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 3.22e-04 | 182 | 80 | 4 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 182 | 80 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.22e-04 | 182 | 80 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.22e-04 | 182 | 80 | 4 | 6c9a48037fa002bc528875538bdaaf15696d68b6 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 3.36e-04 | 184 | 80 | 4 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.36e-04 | 184 | 80 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-04 | 186 | 80 | 4 | 189b75aa98903f1cb65b624524ba6c30df7e42ff | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.50e-04 | 186 | 80 | 4 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|normal_Lung / Location, Cell class and cell subclass | 3.50e-04 | 186 | 80 | 4 | 0987c9a39503eb6c75a2bf4db98b2b2fd46956fb | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.50e-04 | 186 | 80 | 4 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-04 | 186 | 80 | 4 | 261891d0b148e285339ae0b9e36136ceabd9b6f5 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 187 | 80 | 4 | a178b1fed80a0bf83aedb6262493ee17374734b5 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 187 | 80 | 4 | e60cbccf5842f25123fd34b9475759b7424b32e9 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.57e-04 | 187 | 80 | 4 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 187 | 80 | 4 | 2b8eda2812be0be68a6f01aa4038925d3d5b1e65 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 3.64e-04 | 188 | 80 | 4 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-04 | 188 | 80 | 4 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 3.64e-04 | 188 | 80 | 4 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-04 | 189 | 80 | 4 | 284f39dfacec76004daae9dd5317fb7b1f04fa99 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-04 | 189 | 80 | 4 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-04 | 189 | 80 | 4 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 3.72e-04 | 189 | 80 | 4 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.72e-04 | 189 | 80 | 4 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 78 | 80 | 3 | c3360f02624a84930f8b44e12bb6b9aa8284ddc7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 190 | 80 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-04 | 190 | 80 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 190 | 80 | 4 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-04 | 190 | 80 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.79e-04 | 190 | 80 | 4 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 190 | 80 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.79e-04 | 190 | 80 | 4 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.87e-04 | 191 | 80 | 4 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-04 | 192 | 80 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 3.95e-04 | 192 | 80 | 4 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.95e-04 | 192 | 80 | 4 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.02e-04 | 193 | 80 | 4 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.02e-04 | 193 | 80 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-04 | 193 | 80 | 4 | 6e6c5ae39ea880ba809019a7d39f50e4e02007ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-04 | 193 | 80 | 4 | c04ac5884be4245b75d211046f04d76ae0cfb998 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.02e-04 | 193 | 80 | 4 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 80 | 80 | 3 | 0d5770c81a223148e57d625ac2c2ae69ab55b36e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 80 | 80 | 3 | 413796630e7aeff7c68a69dd2d9b8cd8f56163b4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.10e-04 | 194 | 80 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-04 | 194 | 80 | 4 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| Drug | AZD 1480 | 1.60e-07 | 4 | 79 | 3 | ctd:C545606 | |
| Drug | 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide | 4.74e-06 | 10 | 79 | 3 | ctd:C585912 | |
| Drug | Nor-MDP | 1.12e-05 | 13 | 79 | 3 | CID000124876 | |
| Drug | B202 | 1.19e-05 | 2 | 79 | 2 | CID006435965 | |
| Disease | T-Cell Large Granular Lymphocyte Leukemia | 6.72e-06 | 2 | 77 | 2 | C1955861 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 4.25e-05 | 26 | 77 | 3 | DOID:234 (is_implicated_in) | |
| Disease | proline measurement, amino acid measurement | 6.69e-05 | 5 | 77 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | neuroimaging measurement | ZNF462 GMNC ZNF106 STAG1 SPTBN1 GJC1 CC2D2A FRYL GFAP MAP3K1 LUZP1 | 1.00e-04 | 1069 | 77 | 11 | EFO_0004346 |
| Disease | Bell's palsy | 1.50e-04 | 102 | 77 | 4 | EFO_0007167 | |
| Disease | Combined immunodeficiency | 1.70e-04 | 41 | 77 | 3 | C0494261 | |
| Disease | immunoglobulin isotype switching measurement | 2.10e-04 | 44 | 77 | 3 | EFO_0010128 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.98e-04 | 10 | 77 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.36e-04 | 12 | 77 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.36e-04 | 12 | 77 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | velocity of sound measurement | 5.15e-04 | 13 | 77 | 2 | EFO_0005654 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.15e-04 | 13 | 77 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 6.90e-04 | 15 | 77 | 2 | C0265215 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.90e-04 | 15 | 77 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 7.88e-04 | 16 | 77 | 2 | C0079772 | |
| Disease | Usual Interstitial Pneumonia | 1.12e-03 | 19 | 77 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 1.12e-03 | 19 | 77 | 2 | C4721508 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 1.24e-03 | 20 | 77 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 1.37e-03 | 21 | 77 | 2 | C1800706 | |
| Disease | proline measurement | 2.10e-03 | 26 | 77 | 2 | EFO_0009773 | |
| Disease | myocardial infarction | 2.24e-03 | 350 | 77 | 5 | EFO_0000612 | |
| Disease | Fever | 2.26e-03 | 27 | 77 | 2 | C0015967 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.43e-03 | 28 | 77 | 2 | DOID:3717 (is_marker_for) | |
| Disease | Weight Gain | 2.44e-03 | 102 | 77 | 3 | C0043094 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NRRLQHQQLYYSQDD | 1106 | Q99569 | |
| ELQNNLFDRIAQHYA | 211 | F5H4B4 | |
| REDDQYSHLQGNQLR | 166 | P09693 | |
| SQHQRYQGLEQRLEA | 911 | A6NC98 | |
| TRQHQARAQYQDKLA | 171 | Q9NVI7 | |
| HNYRNSSQAVQAVRD | 186 | Q9UDR5 | |
| VHNLNQLLYSQRRAD | 276 | Q53EZ4 | |
| NLVFSRVRNAFHQND | 226 | Q02928 | |
| RVRNAFHQNDTIYSL | 231 | Q02928 | |
| QSARNNYEALNAQLL | 1151 | Q6XZF7 | |
| RQQERHYQLLSALQS | 16 | Q14129 | |
| AHEQNQVLNTNSRYL | 71 | Q8IUZ5 | |
| HDANAQRLARYQEAD | 451 | O60312 | |
| DAANSAAQQYQRRLA | 376 | P46940 | |
| RANDQYLTAAALHNL | 146 | P01583 | |
| QNLNDRLASYLDNVR | 91 | Q7Z3Y7 | |
| NAAFYRLLAQRQQHS | 226 | P58215 | |
| GELRNLVSLHAYNNQ | 671 | A4D1F6 | |
| HQYILNSNRANRRAT | 681 | Q96JG8 | |
| RNEYERSLQNHQFEL | 451 | Q92805 | |
| RNQLLNYRSAISNHG | 1871 | Q16787 | |
| NNGRAQRIYEDHDAT | 451 | P19827 | |
| AARAVRANDINYQDQ | 601 | Q9UK73 | |
| NRLAAESLRNYRNTQ | 1636 | P13535 | |
| NHANRMAAEALRNYR | 1636 | Q9UKX2 | |
| TLNIYQNLNRRQHEH | 641 | P35913 | |
| LDRYSDRNMQINRHQ | 1091 | O94915 | |
| VSNFSRIYHQNQRAD | 406 | Q9NZV8 | |
| NNQLFLYDTHQNLRN | 1211 | P16885 | |
| LYDTHQNLRNANRDA | 1216 | P16885 | |
| RQAKHEANDYRRQLQ | 276 | P14136 | |
| ANARNHDDRESQDIY | 261 | Q86VI3 | |
| GHLLNVDQNQNSYRL | 3841 | Q96RW7 | |
| LAQLYDQYLARHQRN | 431 | Q9P2K1 | |
| NNSRVERLYHDIAQQ | 166 | Q14152 | |
| QERLDLAVQAYSHQN | 346 | P36383 | |
| LQGRADSILAYHQQN | 256 | Q86UU0 | |
| RQQERHYQLLSALQS | 16 | Q9BY27 | |
| RLRNREFALNNENYS | 401 | Q86V48 | |
| TREQLNHYRNVAQNA | 31 | Q8IYT3 | |
| NHYRNVAQNARSELA | 36 | Q8IYT3 | |
| DQHYRALQQLQRDLG | 61 | Q96SL4 | |
| RYCNLNHFNAQNIRG | 531 | A6NIM6 | |
| QYQANIAELTHANNR | 436 | Q68D86 | |
| HSYRDFQTINLNRNV | 666 | Q9Y597 | |
| LQNRRINLLSHDYGD | 136 | Q5EB52 | |
| QSERLQRQLQQEHAY | 461 | Q8N4C8 | |
| SRRNQESNFNLTHYG | 531 | Q13233 | |
| NQLAQALRVYSQHAR | 526 | Q8ND04 | |
| LQEANRRAQEYRHQL | 361 | Q8TAK5 | |
| DYDLCQRISGQRQHN | 151 | Q5TCS8 | |
| RNIVNRNGHQLLDTY | 51 | Q9P2Y5 | |
| ANKNHQDVRSYVRQL | 976 | Q8WZA2 | |
| EENNHLRQYLNSALV | 106 | A6NCL1 | |
| QASSYSRQQRDLHNL | 251 | Q96ER9 | |
| HVQQANQQLSRAADY | 216 | O15400 | |
| SNLRDNYRFAHTNVE | 176 | P30101 | |
| YSRQQNRFNDFDHRE | 761 | Q9NWH9 | |
| QTIINNASYNREIRH | 316 | Q7Z333 | |
| SRSLENAVNRIYHDQ | 6 | Q9BXB7 | |
| HILYNEQRLVREANN | 111 | P51692 | |
| ELLINNQDYRNNHTL | 321 | O15457 | |
| EYQRQQLLADRQAFH | 921 | Q8TAQ2 | |
| RQLQEDAARLQAAYA | 1861 | Q01082 | |
| HILYNEQRLVREANN | 111 | P42229 | |
| AAQLQRFNRDQAHFY | 191 | Q15642 | |
| HRNNKNRNAENASYI | 321 | Q8NA57 | |
| NRNAENASYIHVQRD | 326 | Q8NA57 | |
| NNAIVHYRDDLDLQN | 131 | Q86UF1 | |
| FRLALVNNNNHAEAY | 446 | Q8TAM2 | |
| SDQDAHQYLRLRDQS | 26 | Q9H0U9 | |
| FLQESNVLYQHNLRR | 71 | P40763 | |
| LQAQNSEHQARLDIY | 516 | Q8WXW3 | |
| DLRSYQRLHQHNLQN | 316 | A0A1W2PR48 | |
| SAQNHDYDVALLRLQ | 301 | Q9H3S3 | |
| SIHQDNTQRQYEAER | 241 | Q8WVM7 | |
| FSRHEQRYRLNTNQG | 696 | Q96N46 | |
| HNNEAGRRTVYNLAD | 221 | P41221 | |
| QDSNNSYARQELQRL | 51 | Q8NAM6 | |
| EARQNRHIDLQFSYA | 276 | Q86UK7 | |
| DRALQHYQNHLNIAR | 571 | Q96AY4 | |
| LNHYQSAALARNNSR | 2156 | Q96JM2 | |
| DNNLLQARAALQTAY | 1071 | Q9H2Y7 | |
| GNDLDYNNDRILVRH | 501 | Q96NJ5 |